Literature DB >> 27318490

IgG Autoantibodies Induced by T. cruzi During Pregnancy: Correlation with Gravidity Complications and Early Outcome Assessment of the Newborns.

Miguel Hernán Vicco1,2, Luz Rodeles3,4, Gabriela Soledad Capovilla4, Melina Perrig3, Ana Gabriela Herrera Choque5, Iván Marcipar3, Oscar Bottasso6, Celeste Rodriguez5, Washington Cuña5.   

Abstract

Objective The aim of the present research was to evaluate the correlation of vertically transmitted IgG antibodies induced by T. cruzi and newborn early outcome assessment, mainly birth weight and gestational age. Methods We performed a cross-sectional study with 183 pregnant women (64 with asymptomatic Chagas disease) and their newborns. Both were subjected to complete clinical examination. Peripheral parasitemia was assessed in mother and neonates by parasite detection through microscopic examination of the buffycoat from mother's peripheral and cord blood. Antibodies induced by T. cruzi, such as anti-FRA, anti-B13, anti-p2β and anti-T. cruzi were assessed by immunoassay. Birth weight, general condition evaluation by APGAR Score and gestational age by Capurro Score, were determined in newborns. Results The rate of stillbirth background and pregnancy-induced hypertension were higher in patients with Chagas disease (p = 0.01 and p = 0.02, respectively). Parasitemia was detectable in 17 mothers and 4 newborns. The newborns of mothers with detectable parasitemia presented decreased gestational age (p = 0.006) and body weight (p = 0.04). Mostly all the mothers with Chagas disease and all their newborns have positive values of antibodies induced by T. cruzi; however, only anti-p2β showed to be related to the presence of complication during pregnancy (OR 2.35, p = 0.036), and to low birth weight (OR 1.55, p = 0.02). Conclusions Low birth weight and decreased postnatal estimation of maturity were related to detectable parasitemia in the mother. Also, vertical transmission of T. cruzi-induced autoantibodies might have clinical implication in newborns given the negative association between anti-p2β values and weight.

Entities:  

Keywords:  Anti-p2β; Antibodies; Chagas disease; Low birth weight

Mesh:

Substances:

Year:  2016        PMID: 27318490     DOI: 10.1007/s10995-016-2035-8

Source DB:  PubMed          Journal:  Matern Child Health J        ISSN: 1092-7875


  50 in total

Review 1.  Autoimmunity.

Authors:  Edecio Cunha-Neto; Priscila Camillo Teixeira; Luciana Gabriel Nogueira; Jorge Kalil
Journal:  Adv Parasitol       Date:  2011       Impact factor: 3.870

2.  Trypanosoma cruzi antigen that interacts with the beta1-adrenergic receptor and modifies myocardial contractile activity.

Authors:  Lilian Joensen; Enri Borda; Trudy Kohout; Stephen Perry; Gabriela García; Leonor Sterin-Borda
Journal:  Mol Biochem Parasitol       Date:  2003-04-03       Impact factor: 1.759

Review 3.  Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome.

Authors:  Dominique Langin
Journal:  Pharmacol Res       Date:  2006-03-27       Impact factor: 7.658

4.  Use of full-length recombinant calflagin and its c fragment for improvement of diagnosis of Trypanosoma cruzi infection.

Authors:  Iván S Marcipar; Cintia Roodveldt; Gerardo Corradi; María L Cabeza; Maria Edileuza F Brito; Lucile M Floeter Winter; Alberto J Marcipar; Ariel M Silber
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

5.  Molecular mimicry between cardiac myosin and Trypanosoma cruzi antigen B13: identification of a B13-driven human T cell clone that recognizes cardiac myosin.

Authors:  L C Abel; J Kalil; E Cunha Neto
Journal:  Braz J Med Biol Res       Date:  1997-11       Impact factor: 2.590

6.  Modulatory effects on myocardial physiology induced by an anti-Trypanosoma cruzi monoclonal antibody involve recognition of major antigenic epitopes from beta1-adrenergic and M2-muscarinic cholinergic receptors without requiring receptor cross-linking.

Authors:  Graciela Cremaschi; Marisa M Fernández; Gabriela Gorelik; Juan C Goin; Carlos A Fossati; Norberto W Zwirner; Emilio L Malchiodi
Journal:  J Neuroimmunol       Date:  2004-08       Impact factor: 3.478

7.  Congenital Chagas' disease: diagnostic and clinical aspects.

Authors:  H Freilij; J Altcheh
Journal:  Clin Infect Dis       Date:  1995-09       Impact factor: 9.079

8.  Decreased level of antibodies and cardiac involvement in patients with chronic Chagas heart disease vaccinated with BCG.

Authors:  Miguel Hernán Vicco; Iván Alejandro Bontempi; Luz Rodeles; Agustina Yodice; Iván Sergio Marcipar; Oscar Bottasso
Journal:  Med Microbiol Immunol       Date:  2013-12-29       Impact factor: 3.402

9.  β1-selective adrenoceptor antagonists increase plasma levels of anti-p2β antibodies and decrease cardiac involvement in chronic progressive Chagas heart disease.

Authors:  Miguel H Vicco; Nazarena Pujato; Iván Bontempi; Luz Rodeles; Iván Marcipar; Oscar A Bottasso
Journal:  Can J Cardiol       Date:  2013-12-25       Impact factor: 5.223

Review 10.  IgG placental transfer in healthy and pathological pregnancies.

Authors:  Patricia Palmeira; Camila Quinello; Ana Lúcia Silveira-Lessa; Cláudia Augusta Zago; Magda Carneiro-Sampaio
Journal:  Clin Dev Immunol       Date:  2011-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.